What a Printing Company's Profit-to-Revenue Ratio and Its Rights Issue Have in Common

A Turkish printing company just reported a profit of 113 million Turkish lira in the first half of the year — on revenue of 14 million lira. That is, it earned roughly eight times more in net income than in sales. Then, less than a month later, it filed to raise equity capital from shareholders at a price of 1 lira per share, when those shares trade at about 5.20 lira.

Two facts that, taken together, ask what is actually going on.

The company is Saray Matbaacilik (ticker: SAMAT), listed on Borsa Istanbul. It makes stationery, paper products, and packaging — including printed materials for the tobacco industry. It's a small-cap with roughly 112 million shares outstanding and a market value around 590 million lira. Not a household name, and not one you'd normally expect to see doing something that looks like it's trying to be a different kind of business.

Here's the plumbing.

The rights issue mechanics

In April 2026, Saray Matbaacilik's board approved a capital increase that would triple the company's share capital — adding 224.8 million lira in new shares on top of the existing 112.4 million lira. The company prepared a prospectus and filed the application with Turkey's Capital Markets Board in May. Then, in September, it revised the plan down. Not canceled — revised. The new proposal adds only 112.4 million lira, doubling rather than tripling the capital. A "more moderate capital structure strategy", the company called it.

The structure is a standard Turkish rights issue. Existing shareholders get the right to subscribe to new shares proportional to their current holdings, at par value — 1 lira per share. The subscription window runs for 15 days. Any unsubscribed shares are sold on the exchange's primary market for two business days at no less than nominal value. Whatever is still left gets cancelled.

The important detail is the pricing gap. The shares trade at roughly 5.20 lira. The new shares cost 1 lira. That is a discount of about 80%. If you hold one SAMAT share today, you get the right to buy one new share at one-fifth the market price. That right itself has value — it's not free money, because the stock price will adjust downward when the new shares hit the market. But it is a substantial per-share benefit.

Here's how the math works. Right now, there are 112.4 million shares at roughly 5.20 lira each, for a market cap around 585 million lira. The company raises 112.4 million lira by issuing 112.4 million new shares. After the rights issue, there are 224.8 million shares and, ignoring any business effect, the ex-rights share price drops to roughly 3.11 lira. Your one share is worth less, but if you subscribed, you now hold two shares worth that same amount. The value is preserved through the subscription right, not through the post-issue share price.

If you don't subscribe, your single share gets diluted — it's now one of 224.8 million instead of 112.4 million. If you sell your subscription right before the deadline, you can capture most of that value. The right is basically a cheap call option on a stock that's already trading above its exercise price.

The profit question

This is where the earlier fact comes in. For the first half of 2026, Saray Matbaacilik reported net income of 113.4 million lira, versus a net loss of 15.7 million lira in the same period last year. Revenue was 14 million lira, down from 20 million. The company lost money on its operations — or at least, it didn't earn enough from printing stationery and paper to generate 113 million lira in profit.

The second quarter alone saw revenue of 9.7 million lira against net income of 101 million lira. The gap between operating revenue and bottom-line profit is not explained by margin expansion. It's the kind of gap that comes from something outside the core business — a one-time gain, a revaluation, a write-down reversal, an asset sale. The company's earnings release doesn't spell out the breakdown in English-language reporting, but the pattern is clear: the half-year profit is not a reflection of printing demand.

This matters for the capital raise. The standard narrative for a rights issue is that a company needs money — for expansion, debt reduction, working capital, or an acquisition. But Saray Matbaacilik just reported what looks like a large non-operating windfall and then immediately asked shareholders for more cash. The timing suggests either that the company's balance sheet is weaker than the headline profit implies, or that the capital raise serves a purpose beyond funding operations.

The original plan was to triple the capital. The revised plan halves that ambition. Both plans still raise substantial cash relative to the company's operating scale — 112 million lira in new equity against annualized operating revenue of roughly 28 million lira. The company would be holding a cash pile that dwarfed its sales.

What this kind of structure usually means

In Turkish listed companies, rights issues at par value with a wide market-to-par discount are common enough to have a reputation. The question isn't whether the structure works — it does, mechanically. The question is what it does to the economics of the existing position.

For a company like Saray Matbaacilik, with a tiny operating business and a market cap that seems disconnected from those operations, the rights issue functions as a way to bring capital into the company without diluting control — the proportional subscription preserves each shareholder's voting share. The cash the company receives gets added to its balance sheet, which can make the company look larger, more capitalized, and potentially more credible for borrowing or partnership purposes.

The scaled-back plan is interesting precisely because the company chose to raise less. The original prospectus had been filed for the larger amount. A system issue during the May filing provided the administrative excuse, but the decision to revise downward is a real one. It suggests the board recalculated — perhaps the 200% increase was too aggressive, perhaps the market wasn't ready for it, or perhaps the company's actual funding needs are smaller than the original plan implied. A smaller raise means less cash inflow but also less dilution pressure. It's a more conservative position.

What you'd actually be doing if you held this stock

If you owned SAMAT going into the rights issue, your options are straightforward. Subscribe at 1 lira per share and double your share count while keeping the same economic exposure. Don't subscribe and let your position dilute. Or sell the subscription right before the window closes, which is essentially cashing out the value of the discount.

The unusual part is that the company needs capital despite reporting a profit that, on paper, would cover the entire raise. That mismatch between the income statement and the capital structure move is what makes this worth paying attention to. The profit looks real but non-recurring. The capital raise is a structural decision, not a quarterly blip. The two don't cancel each other out.

The practical takeaway is that the rights issue itself is a mechanism, not a signal of business strength. It's the plumbing for moving money from shareholders into the company, and the plumbing works fine. Whether the money serves the business depends on what the company does with it — and for a printing company in Turkey with 28 million lira in annualized revenue, that's the question the filings haven't answered yet.